Condition: Lung Cancer Stage IV · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.
This description comes directly from the study's public registry record.
Rocco Trisolini, MD · 0630154163 · rocco.trisolini@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS | Roma, Italy | Recruiting |
| Istituto Nazionale Tumori Regina Elena | Roma, Italy | Not Yet Recruiting |
| Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Roma, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06076005